Search research articles
Contact Us
Filters
Showing results (101-110 of 114) with videos related to
Page
of 12
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 16, 2020
Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study
F Pagès, T André, J Taieb, et al.
Blood
|
July 14, 2017
FDG-PET-driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study
R-O Casasnovas, L Ysebaert, C Thieblemont, et al.
Pediatrics
|
October 1, 1996
Idiopathic disseminated bacillus Calmette-Guérin infection: a French national retrospective study
J L Casanova, S Blanche, J F Emile, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 9, 2014
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset
H Blons, J F Emile, K Le Malicot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 13, 2020
Corrigendum to 'Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study': Annals of Oncology 2020; Volume 31: 921-929
F Pagès, T André, J Taieb, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 30, 2016
Adjuvant FOLFOX +/- cetuximab in full RAS and BRAF wildtype stage III colon cancer patients
J Taieb, R Balogoun, K Le Malicot, et al.
Translational Oncology
|
December 15, 2021
Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict adjuvant chemosensitivity in pancreatic cancer
R Nicolle, O Gayet, M Bigonnet, et al.
Annales De Pathologie
|
November 28, 2006
[Recommendations for the management of gastro-intestinal stromal tumors]
A Le Cesne, B Landi, S Bonvalot, et al.
Nature Genetics
|
April 7, 1999
A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection
E Jouanguy, S Lamhamedi-Cherradi, D Lammas, et al.
Medical Oncology (Northwood, London, England)
|
September 29, 2011
Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs
J F Emile, S Brahimi, J M Coindre, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 114) with videos related to
Sort By:
Page
of 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 16, 2020
Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study
F Pagès, T André, J Taieb, et al.
Blood
|
July 14, 2017
FDG-PET-driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study
R-O Casasnovas, L Ysebaert, C Thieblemont, et al.
Pediatrics
|
October 1, 1996
Idiopathic disseminated bacillus Calmette-Guérin infection: a French national retrospective study
J L Casanova, S Blanche, J F Emile, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 9, 2014
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset
H Blons, J F Emile, K Le Malicot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 13, 2020
Corrigendum to 'Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study': Annals of Oncology 2020; Volume 31: 921-929
F Pagès, T André, J Taieb, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 30, 2016
Adjuvant FOLFOX +/- cetuximab in full RAS and BRAF wildtype stage III colon cancer patients
J Taieb, R Balogoun, K Le Malicot, et al.
Translational Oncology
|
December 15, 2021
Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict adjuvant chemosensitivity in pancreatic cancer
R Nicolle, O Gayet, M Bigonnet, et al.
Annales De Pathologie
|
November 28, 2006
[Recommendations for the management of gastro-intestinal stromal tumors]
A Le Cesne, B Landi, S Bonvalot, et al.
Nature Genetics
|
April 7, 1999
A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection
E Jouanguy, S Lamhamedi-Cherradi, D Lammas, et al.
Medical Oncology (Northwood, London, England)
|
September 29, 2011
Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs
J F Emile, S Brahimi, J M Coindre, et al.
Page
of 12